Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elizabeth J, de Koster"'
Autor:
Elizabeth J de Koster, Olga Husson, Eveline W C M van Dam, G Sophie Mijnhout, Romana T Netea-Maier, Wim J G Oyen, Marieke Snel, Lioe-Fee de Geus-Oei, Dennis Vriens
Publikováno v:
Endocrine Connections, Vol 11, Iss 8, Pp 1-12 (2022)
Objective: This study assessed the health-related quality of life (HRQoL) in patients undergoing 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT for an indeterminate (Bethesda III/IV) thyroid nodule. FDG-PET/CT accurately rules out malignancy and preven
Externí odkaz:
https://doaj.org/article/05489f8b08c4475da624c16b7729c0c0
Autor:
Elizabeth J. de Koster, Taban Sulaiman, Jaap F. Hamming, Abbey Schepers, Marieke Snel, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Dennis Vriens
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 553 (2021)
Changing insights regarding radioiodine (I-131) administration in differentiated thyroid carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy (DxWBS). Our retrospective study qualitatively and semi-quantitatively
Externí odkaz:
https://doaj.org/article/a5f1368c324748a986a196609abb3bb9
Autor:
Elizabeth J, de Koster, Wyanne A, Noortman, Jacob M, Mostert, Jan, Booij, Catherine B, Brouwer, Bart, de Keizer, John M H, de Klerk, Wim J G, Oyen, Floris H P, van Velden, Lioe-Fee, de Geus-Oei, Dennis, Vriens
Publikováno v:
European journal of nuclear medicine and molecular imaging. 49(7)
To evaluate whether quantitative [Prospectively included patients with a Bethesda III or IV thyroid nodule underwent [Of 123 included patients, 84 (68%) index nodules were visually [Quantitative [This trial is registered with ClinicalTrials.gov: NCT0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::805fe458cd7f23fceea7f2cf72ae0a30
https://pubmed.ncbi.nlm.nih.gov/35138444
https://pubmed.ncbi.nlm.nih.gov/35138444
Autor:
Taban Sulaiman, Abbey Schepers, Jaap F. Hamming, Elizabeth J. de Koster, Lioe-Fee de Geus-Oei, Dennis Vriens, Marieke Snel, Floris van Velden
Publikováno v:
Diagnostics, 11(3). MDPI
Diagnostics
Volume 11
Issue 3
Diagnostics, 11, 3
Diagnostics, 11
Diagnostics, Vol 11, Iss 553, p 553 (2021)
DIAGNOSTICS
Diagnostics
Volume 11
Issue 3
Diagnostics, 11, 3
Diagnostics, 11
Diagnostics, Vol 11, Iss 553, p 553 (2021)
DIAGNOSTICS
Changing insights regarding radioiodine (I-131) administration in differentiated thyroid carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy (DxWBS). Our retrospective study qualitatively and semi-quantitatively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::877ddc80aac70f080fb1d22a79143149
https://doi.org/10.3390/diagnostics11030553
https://doi.org/10.3390/diagnostics11030553
Autor:
Simona Maria Fragomeni, Giorgia Garganese, Elizabeth Katherine Anna Triumbari, Angela Collarino, Elizabeth J. de Koster, Vittoria Rufini
Publikováno v:
Clinical Nuclear Medicine, 46, 125-132
Clinical Nuclear Medicine, 46(2), 125-132. LIPPINCOTT WILLIAMS & WILKINS
Clinical Nuclear Medicine, 46, 2, pp. 125-132
Clinical Nuclear Medicine, 46(2), 125-132. LIPPINCOTT WILLIAMS & WILKINS
Clinical Nuclear Medicine, 46, 2, pp. 125-132
Aim The aims of this study were to determine the role of 18F-FDG PET/CT in vulvar cancer patients and to extract summary estimates of its diagnostic performance for preoperative lymph node staging. Patients and methods PubMed/Medline and Embase datab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c37f0c8b34cda74a5d3e8e0f73e7599
https://pubmed.ncbi.nlm.nih.gov/33234921
https://pubmed.ncbi.nlm.nih.gov/33234921
Autor:
Angela Collarino, Renato A. Valdés Olmos, Lioe-Fee de Geus-Oei, Lenka M. Pereira Arias-Bouda, Elizabeth J. de Koster
Publikováno v:
Clinical breast cancer, 18(1), 9-18. Elsevier
Clinical Breast Cancer, 18(1), 9-18
Clinical Breast Cancer, 18, 9-18
Clinical Breast Cancer, 18(1), 9-18. CIG MEDIA GROUP, LP
Clinical Breast Cancer, 18, 1, pp. 9-18
Clinical Breast Cancer, 18(1), 9-18
Clinical Breast Cancer, 18, 9-18
Clinical Breast Cancer, 18(1), 9-18. CIG MEDIA GROUP, LP
Clinical Breast Cancer, 18, 1, pp. 9-18
In breast cancer, interest in technetium-99m (Tc-99m) sestamibi-based therapy monitoring is increasing owing to the growing use of Tc-99m-sestamibi-based molecular breast imaging. In the present meta-analysis of 529 patients, Tc-99m-sestamibi planar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea7b225af5b947f8bb2f33bdfe82903
https://hdl.handle.net/1887/95881
https://hdl.handle.net/1887/95881